Universität zu Köln

Journal Article

Baues, Christian, Trommer-Nestler, Maike, Jablonska, Karolina, Broeckelmann, Paul J., Schlaak, Max, von Bergwelt-Baildon, Michael, Engert, Andreas, Semrau, Robert, Marnitz, Simone and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2017). Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy, 9 (5). S. 423 - 434. LONDON: FUTURE MEDICINE LTD. ISSN 1750-7448

Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J. (2015). Consolidated aspects in the treatment of hodgkin lymphoma. Drug. Cell Ther. Hematol., 3 (3). S. 130 - 144. PAVIA: PAGEPRESS PUBL. ISSN 2281-4884

Broeckelmann, Paul J., Angelopoulou, Maria K. and Vassilakopoulos, Theodoros P. (2016). Prognostic factors in Hodgkin lymphoma. Semin. Hematol., 53 (3). S. 155 - 165. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

Broeckelmann, Paul J., Borchmann, Peter and Engert, Andreas (2016). Current and future immunotherapeutic approaches in Hodgkin lymphoma. Leuk. Lymphoma, 57 (9). S. 2014 - 2025. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Broeckelmann, Paul J., Borchmann, Sven, Borchmann, Peter and Engert, Andreas (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. J. Clin. Oncol., 38 (32). S. 3816 - 3820. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Broeckelmann, Paul J., Buehnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa, V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial. Blood, 140. S. 1753 - 1756. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Eichenauer, Dennis A., Jakob, Tina, Follmann, Markus ORCID: 0000-0003-3790-5578, Engert, Andreas and Skoetz, Nicole (2018). Hodgkin Lymphoma in Adults. Dtsch. Arztebl. Int., 115 (31-32). S. 535 - 546. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452

Broeckelmann, Paul J. and Engert, Andreas (2017). Checkpoint Inhibition in Hodgkin Lymphoma - a Review. Oncol. Res. Treat., 40 (11). S. 654 - 660. BASEL: KARGER. ISSN 2296-5262

Broeckelmann, Paul J. and Engert, Andreas (2015). The GHSG Approach to Treating Hodgkin's Lymphoma. Curr. Hematol. Malig. Rep., 10 (3). S. 256 - 266. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X

Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Broeckelmann, Paul J., Goergen, Helen, Kohnhorst, Charlotte, Von Tresckow, Bastian, Moccia, Alden, Markova, Jana, Meissner, Julia, Kerkhoff, Andrea, Ludwig, Wolf-Dieter, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2017). Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. J. Clin. Oncol., 35 (13). S. 1444 - 1455. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Broeckelmann, Paul J., McMullen, Suzanne, Ben Wilson, J., Mueller, Kerstin, Goring, Sarah, Stamatoullas, Aspasia, Zagadailov, Erin, Gautam, Ashish, Huebner, Dirk, Dalal, Mehul and Illidge, Tim (2019). Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom. Br. J. Haematol., 184 (2). S. 202 - 215. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., Mueller, Horst, Casasnovas, Olivier, Hutchings, Martin ORCID: 0000-0003-3873-1741, von Tresckow, Bastian, Borchmann, Peter, Moskowitz, Craig and Engert, Andreas (2015). Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Mueller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis. Leukemia, 36 (3). S. 772 - 781. LONDON: SPRINGERNATURE. ISSN 1476-5551

Broeckelmann, Paul J., Sasse, Stephanie and Engert, Andreas (2018). Balancing risk and benefit in early-stage classical Hodgkin lymphoma. Blood, 131 (15). S. 1666 - 1679. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Broeckelmann, Paul J., Zagadailov, Erin A., Corman, Shelby L., Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R. and Illidge, Tim (2017). Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. Eur. J. Haematol., 99 (6). S. 553 - 559. HOBOKEN: WILEY. ISSN 1600-0609

Broeckelmann, Paul J. and von Tresckow, Bastian ORCID: 0000-0003-1410-4487 (2020). Risk stratification and prognostic biomarkers in relapsed Hodgkin lymphoma. Br. J. Haematol., 190 (6). S. 813 - 815. HOBOKEN: WILEY. ISSN 1365-2141

Broeckelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2018). Relapsed or refractory classical Hodgkin's lymphoma. Novel therapeutic approaches. Onkologe, 24 (4). S. 322 - 329. NEW YORK: SPRINGER. ISSN 1433-0415

Cheah, Chan Y., Broeckelmann, Paul J., Chihara, Dai ORCID: 0000-0002-1153-2294, Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec C., Augustson, Bradley, Vose, Julie, Bartlett, Nancy L., Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina, Oki, Yasuhiro and Fanale, Michelle A. (2016). Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Am. J. Hematol., 91 (9). S. 894 - 900. HOBOKEN: WILEY. ISSN 1096-8652

Cheah, Chan Yoon, Broeckelmann, Paul J., Moskowitz, Alison J., Engert, Andreas, Jerkeman, Mats, El-Galaly, Tarec Christoffer, Vose, Julie, Villa, Diego, Connors, Joseph M., Feldman, Tatyana, Chihara, Dai, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina S., Oki, Yasuhiro and Fanale, Michelle A. (2015). Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Garcia-Marquez, Maria A., Thelen, Martin ORCID: 0000-0002-2785-9726, Reinke, Sarah, Keller, Diandra, Wennhold, Kerstin, Lehmann, Jonas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Borchmann, Sven ORCID: 0000-0001-6662-6864, Rosenwald, Andreas, Sasse, Stephanie, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Borchmann, Peter, Engert, Andreas, Klapper, Wolfram, Von Bergwelt-Baildon, Michael, Broeckelmann, Paul J. and Schloesser, Hans A. (2022). Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. Leukemia, 36 (3). S. 760 - 772. LONDON: SPRINGERNATURE. ISSN 1476-5551

Gerhard-Hartmann, Elena ORCID: 0000-0003-2134-2774, Goergen, Helen, Broeckelmann, Paul J., Mottok, Anja, Steinmueller, Tabea ORCID: 0000-0001-7099-1223, Grund, Johanna, Zamo, Alberto, Ben-Neriah, Susana, Sasse, Stephanie, Borchmann, Sven ORCID: 0000-0001-6662-6864, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Klapper, Wolfram and Rosenwald, Andreas (2022). 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. Br. J. Haematol., 196 (1). S. 116 - 127. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609

Graef, Claus Moritz, Goedel, Philipp, Falderbaum, Philipp, Balke-Want, Hyatt, Simon, Florian ORCID: 0000-0002-2700-3717, Sieg, Noelle, Naendrup, Jan-Hendrik, Neumann, Marie Anne-Catherine ORCID: 0000-0002-2396-6110, Gillessen, Sarah, Broeckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2022). Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma. Eur. J. Haematol., 108 (5). S. 403 - 413. HOBOKEN: WILEY. ISSN 1600-0609

Hokland, Peter ORCID: 0000-0002-1177-9756, Shah, Mansi, David, Kevin, Evens, Andrew, Auer, Rebecca, Ledieu, Rifca, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, Korula, Anu, Mathews, Vikram, Owattanapanich, Weerapat and Trotman, Judith (2020). How I treat advanced Hodgkin lymphoma - a global view. Br. J. Haematol., 190 (6). S. 837 - 851. HOBOKEN: WILEY. ISSN 1365-2141

Hude, Ida, Sasse, Stephanie, Broeckelmann, Paul J., von Tresckow, Bastian, Momotow, Jesko, Engert, Andreas and Borchmann, Sven (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. Br. J. Haematol., 181 (6). S. 837 - 841. HOBOKEN: WILEY. ISSN 1365-2141

Hude, Ida, Sasse, Stephanie, Engert, Andreas and Broeckelmann, Paul J. (2017). The emerging role of immune checkpoint inhibition in malignant lymphoma. Haematologica, 102 (1). S. 30 - 43. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Koutzamanidis, Rafaela, Mentzer, Dirk, Knauss, Samuel, Broeckelmann, Paul J., Hassel, Jessica Cecile, Ugurel-Becker, Selma, Pavel, Marianne, Nickel, Florian, Landendinger, Melanie, Fuchs, Florian, Meidenbauer, Norbert, Jefremow, Andre, Manger, Bernhard, Gutzmer, Ralf, Loguai, Carmen, Kaehler, Katharina, Zimmer, Lisa, Berking, Carola, Keller-Stanislawski, Brigitte, Heinzerling, Lucie, Erdrnann, Michael, Kirchberger, Michael C. and Toussaint, Frederic (2020). Serio - Side Effect Registry in Immuno-Oncology. Oncol. Res. Treat., 43. S. 231 - 232. BASEL: KARGER. ISSN 2296-5262

Kramer, Rafaela ORCID: 0000-0002-3967-5289, Zaremba, Anne, Moreira, Alvaro, Ugurel, Selma, Johnson, Douglas B., Hassel, Jessica C., Salzmann, Martin, Gesierich, Anja, Weppler, Alison ORCID: 0000-0003-3769-490X, Spain, Lavinia, Loquai, Carmen, Dudda, Milena, Pfoehler, Claudia, Hepner, Adriana ORCID: 0000-0002-8716-9401, Long, Georgina, V, Menzies, Alexander M., Carlino, Matteo S., Sachse, Michael M., Lebbe, Celeste, Baroudjian, Barouyr, Enokida, Tomohiro, Tahara, Makoto, Schlaak, Max, Hayani, Kinan, Broeckelmann, Paul J., Meier, Friedegund, Reinhardt, Lydia, Friedlander, Philip, Eigentler, Thomas, Kaehler, Katharina C., Berking, Carola, Zimmer, Lisa ORCID: 0000-0002-3680-3521 and Heinzerling, Lucie (2021). Hematological immune related adverse events after treatment with immune checkpoint inhibitors. Eur. J. Cancer, 147. S. 170 - 182. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Hirsch, Caroline, Andreas, Marike, Boehm, Lena, Broeckelmann, Paul J., Di Cristanziano, Veronica, Golinski, Martin, Hausinger, Renate Ilona, Mellinghoff, Sibylle ORCID: 0000-0003-3928-2503, Lange, Berit, Lischetzki, Tina, Kappler, Verena, Mikolajewska, Agata, Monsef, Ina, Park, Yun Soo, Piechotta, Vanessa, Schmaderer, Christoph, Stegemann, Miriam, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Weber, Florencia, Weibel, Stephanie, Stephani, Caspar and Skoetz, Nicole (2022). Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review. Cochrane Database Syst Rev. (8). HOBOKEN: WILEY. ISSN 1361-6137

Mellinghoff, Sibylle C., Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Dahlke, Christine, Addo, Marylyn M., Cornely, Oliver A., Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Gruell, Henning and Broeckelmann, Paul J. (2021). Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19. Front. Immunol., 12. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Momotow, Jesko, Buehnen, Ina, Trautmann-Grill, Karolin, Kobbe, Guido, Hahn, Dennis, Schroers, Roland ORCID: 0000-0003-2744-5491, Heinrich, Bernhard, Gaska, Tobias, Forstbauer, Helmut, Schmidt, Burkhard, Boger, Regina, Huettmann, Andreas, Heil, Gerhard, Kraemer, Doris M., Krueger, William, Zeremski, Vanja, Grobe, Norbert, Jentsch-Ullrich, Kathleen, Griesinger, Frank, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Engert, Andreas and Broeckelmann, Paul J. (2022). Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. Br. J. Haematol., 198 (2). S. 401 - 405. HOBOKEN: WILEY. ISSN 1365-2141

Piechotta, Vanessa, Mellinghoff, Sibylle C., Hirsch, Caroline ORCID: 0000-0002-2011-1010, Brinkmann, Alice, Iannizzi, Claire, Kreuzberger, Nina ORCID: 0000-0001-8922-0488, Adams, Anne ORCID: 0000-0003-3286-1131, Monsef, Ina, Stemler, Jannik, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Broeckelmann, Paul J. and Skoetz, Nicole (2022). Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review. Blood Cancer J., 12 (5). LONDON: SPRINGERNATURE. ISSN 2044-5385

Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sieg, Noelle, Naendrup, Jan-Hendrik, Goedel, Philipp, Balke-Want, Hyatt, Simon, Florian, Deckert, Martina, Gillessen, Sarah, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel (2021). Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine. Eur. J. Haematol., 107 (2). S. 202 - 211. HOBOKEN: WILEY. ISSN 1600-0609

Simon, Florian, Garcia Borrega, Jorge and Broeckelmann, Paul J. (2020). Toxicities of novel therapies for hematologic malignancies. Expert Rev. Hematol., 13 (3). S. 241 - 258. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1747-4094

Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Mueller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten and Broeckelmann, Paul J. (2021). Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin. Cancer Res., 27 (2). S. 402 - 408. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Wienemann, Hendrik, Broeckelmann, Paul J. and Adam, Matti ORCID: 0000-0002-6990-8135 (2020). Complete remission of Loeffler's endocarditis with Imatinib in a myeloid and lymphoid neoplasm associated with eosinophilia. Dtsch. Med. Wochenschr., 145 (1). S. 36 - 40. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Zagadailov, Erin A., Corman, Shelby, Chirikov, Viktor, Johnson, Courtney, Macahilig, Cynthia, Seal, Brian, Dalal, Mehul R., Broeckelmann, Paul J. and Illidge, Tim (2018). Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany. Leuk. Lymphoma, 59 (6). S. 1413 - 1420. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403